Home › NDC Lookup › Labelers › Mylan Institutional Llc

Mylan Institutional Llc NDCs and Package Codes

This page lists NDC package records associated with labeler code 67457 (Mylan Institutional Llc) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

151
Package NDCs
179
Products
171
Active listings
8
Discontinued
73
Ingredients
21
Therapeutic classes
9
Dosage forms
30
With NADAC pricing

Portfolio

By therapeutic class
PLATELET AGGREGATION INHIBITORS 3
CHEMOTHERAPY RESCUE/ANTIDOTE AGENT... 3
CARDIOVASCULAR DIAGNOSTICS,NON-RAD... 2
VENOSCLEROSING AGENTS 2
ANTINEOPLASTIC EGF RECEPTOR BLOCKE... 2
NEUROMUSCULAR BLOCKING AGENTS 2
AMINOGLYCOSIDE ANTIBIOTICS 2
OPIOID ANTAGONISTS 2
Top ingredients
fondaparinux sodium 12
Vancomycin Hydrochloride 9
octreotide acetate 9
Dexamethasone Sodium Phosphate 8
Heparin Sodium 6
Famotidine 6
DOCETAXEL ANHYDROUS 6
Remifentanil Hydrochloride 6
Iron Sucrose 6
Levetiracetam 4
By dosage form
INJECTION, SOLUTION 85
INJECTION 32
INJECTION, POWDER, LYOPHILIZED, FO... 32
INJECTION, SOLUTION, CONCENTRATE 9
KIT 8
INJECTION, POWDER, LYOPHILIZED, FO... 6
INJECTION, SUSPENSION 4
SOLUTION 2

Browse records — 179 products

Drug / product Billing NDC NADAC / unit Status
OCTREOTIDE ACETATE KIT Mylan · NDC 67457-0762-30 · J2353 · 1 KIT in 1 KIT (67457-762-30) * 6 mL in 1 VIAL (67457-760-30) * 2 mL in 1 SYRINGE (67457-761-02) 67457-0762-30 — On market View →
OCTREOTIDE ACETATE KIT Mylan · NDC 67457-0759-20 · J2353 · 1 KIT in 1 KIT (67457-759-20) * 6 mL in 1 VIAL (67457-757-20) * 2 mL in 1 SYRINGE (67457-758-02) 67457-0759-20 — On market View →
OCTREOTIDE ACETATE KIT Mylan · NDC 67457-0762-30 · J2353 · 1 KIT in 1 KIT (67457-762-30) * 6 mL in 1 VIAL (67457-760-30) * 2 mL in 1 SYRINGE (67457-761-02) 67457-0762-30 — On market View →
OCTREOTIDE ACETATE KIT Mylan · NDC 67457-0756-10 · J2353 · 1 KIT in 1 KIT (67457-756-10) * 6 mL in 1 VIAL (67457-754-10) * 2 mL in 1 SYRINGE (67457-755-02) 67457-0756-10 — On market View →
OGIVRI trastuzumab KIT Mylan · NDC 67457-0847-44 · Q5114 · 1 KIT in 1 CARTON (67457-847-44) * 20 mL in 1 VIAL, MULTI-DOSE (67457-845-50) * 20 mL in 1 VIAL (67457-846-20) 67457-0847-44 — On market View →
OGIVRI trastuzumab 150 mg/7.4mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Mylan · NDC 67457-0991-15 · Q5114 · 1 VIAL in 1 CARTON (67457-991-15) / 15 mL in 1 VIAL 67457-0991-15 — On market View →
Oxaliplatin 5 mg/mL INJECTION, SOLUTION Mylan · NDC 67457-0442-20 · J9263 · 1 VIAL in 1 CARTON (67457-442-20) / 20 mL in 1 VIAL 67457-0442-20 — On market View →
Oxaliplatin 5 mg/mL INJECTION, SOLUTION Mylan · NDC 67457-0469-10 · J9263 · 1 VIAL in 1 CARTON (67457-469-10) / 10 mL in 1 VIAL 67457-0469-10 — On market View →
PACLITAXEL 100 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION Mylan · NDC 67457-0937-50 · J9264 · 20 mL in 1 VIAL (67457-937-50) 67457-0937-50 — On market View →
PACLITAXEL 100 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION Mylan · NDC 67457-0937-50 · J9264 · 20 mL in 1 VIAL (67457-937-50) 67457-0937-50 — On market View →
Palonosetron Hydrochloride .25 mg/5mL INJECTION, SOLUTION Mylan · NDC 67457-0317-25 · J2469 · 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-317-25) / 5 mL in 1 VIAL, SINGLE-DOSE 67457-0317-25 — On market View →
Pamidronate Disodium 9 mg/mL INJECTION Mylan · NDC 67457-0446-10 · J2430 · 1 VIAL in 1 CARTON (67457-446-10) / 10 mL in 1 VIAL 67457-0446-10 — On market View →
Pamidronate Disodium 3 mg/mL INJECTION Mylan · NDC 67457-0430-10 · J2430 · 1 VIAL in 1 CARTON (67457-430-10) / 10 mL in 1 VIAL 67457-0430-10 — On market View →
posaconazole 18 mg/mL SOLUTION Mylan · NDC 67457-0665-20 · J1837 · 1 VIAL, GLASS in 1 CARTON (67457-665-20) / 16.7 mL in 1 VIAL, GLASS 67457-0665-20 — On market View →
posaconazole 18 mg/mL SOLUTION Mylan · NDC 67457-0665-20 · J1837 · 1 VIAL, GLASS in 1 CARTON (67457-665-20) / 16.7 mL in 1 VIAL, GLASS 67457-0665-20 — On market View →
prochlorperazine edisylate 5 mg/mL INJECTION Mylan · NDC 67457-0640-02 · J0780 · 25 VIAL in 1 CARTON (67457-640-02) / 2 mL in 1 VIAL (67457-640-00) 67457-0640-02 — On market View →
Regadenoson .4 mg/5mL INJECTION Mylan · NDC 67457-0994-05 · J2785 · 1 SYRINGE in 1 CARTON (67457-994-05) / 5 mL in 1 SYRINGE 67457-0994-05 — Discontinued View →
Rifampin 600 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Mylan · NDC 67457-0445-60 · J2804 · 1 VIAL in 1 CARTON (67457-445-60) / 10 mL in 1 VIAL 67457-0445-60 — On market View →
RIMSO-50 Dimethyl Sulfoxide .54 g/mL IRRIGANT Mylan · NDC 67457-0177-50 · J1212 · 1 VIAL, GLASS in 1 CARTON (67457-177-50) / 50 mL in 1 VIAL, GLASS 67457-0177-50 — On market View →
Rocuronium Bromide 10 mg/mL INJECTION Mylan · NDC 67457-0228-05 · 10 VIAL, MULTI-DOSE in 1 CARTON (67457-228-05) / 5 mL in 1 VIAL, MULTI-DOSE (67457-228-00) 67457-0228-05 $0.394 /unit · NADAC On market View →
ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Mylan · NDC 67457-0799-99 · J2795 · 10 POUCH in 1 CARTON (67457-799-99) / 1 BAG in 1 POUCH (67457-799-20) / 200 mL in 1 BAG 67457-0799-99 — On market View →
ROPIVACAINE HYDROCHLORIDE 2 mg/mL INJECTION, SOLUTION Mylan · NDC 67457-0798-99 · J2795 · 10 POUCH in 1 CARTON (67457-798-99) / 1 BAG in 1 POUCH (67457-798-10) / 100 mL in 1 BAG 67457-0798-99 — On market View →
Sodium nitroprusside 25 mg/mL INJECTION, SOLUTION, CONCENTRATE Mylan · NDC 67457-0839-02 · 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-839-02) / 2 mL in 1 VIAL, SINGLE-DOSE 67457-0839-02 — On market View →
Sodium nitroprusside 25 mg/mL INJECTION, SOLUTION, CONCENTRATE Mylan · NDC 67457-0999-02 · 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-999-02) / 2 mL in 1 VIAL, SINGLE-DOSE 67457-0999-02 — On market View →
Sodium nitroprusside 25 mg/mL INJECTION, SOLUTION, CONCENTRATE Mylan · NDC 67457-0839-02 · 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-839-02) / 2 mL in 1 VIAL, SINGLE-DOSE 67457-0839-02 — On market View →
Sotradecol tetradecyl hydrogen sulfate (ester) 10 mg/mL INJECTION, SOLUTION Mylan · NDC 67457-0162-02 · 5 VIAL, MULTI-DOSE in 1 CARTON (67457-162-02) / 2 mL in 1 VIAL, MULTI-DOSE (67457-162-00) 67457-0162-02 — On market View →
Sotradecol tetradecyl hydrogen sulfate (ester) 30 mg/mL INJECTION, SOLUTION Mylan · NDC 67457-0163-02 · 5 VIAL, MULTI-DOSE in 1 CARTON (67457-163-02) / 2 mL in 1 VIAL, MULTI-DOSE (67457-163-00) 67457-0163-02 — On market View →
Sugammadex 100 mg/mL INJECTION, SOLUTION Mylan · NDC 67457-0970-05 · 10 VIAL, SINGLE-DOSE in 1 CARTON (67457-970-05) / 5 mL in 1 VIAL, SINGLE-DOSE (67457-970-00) 67457-0970-05 — On market View →
Sugammadex 100 mg/mL INJECTION, SOLUTION Mylan · NDC 67457-0969-02 · 10 VIAL, SINGLE-DOSE in 1 CARTON (67457-969-02) / 2 mL in 1 VIAL, SINGLE-DOSE (67457-969-00) 67457-0969-02 — On market View →
Thiamine Hydrochloride 100 mg/mL INJECTION, SOLUTION Mylan · NDC 67457-0196-02 · J3411 · 25 VIAL, MULTI-DOSE in 1 CARTON (67457-196-02) / 2 mL in 1 VIAL, MULTI-DOSE (67457-196-00) 67457-0196-02 $2.247 /unit · NADAC On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.